About
Hemoglobin-based oxygen carrier
Areas of Focus
Categories
Biologics & BiopharmaceuticalNJ, NY, PA
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
0
As Collaborator
3
Total Enrollment
50
By Phase
NA: 1
By Status
ENROLLING_BY_INVITATION: 1NO_LONGER_AVAILABLE: 1AVAILABLE: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT01881503Collaborator
Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening Anemia
NAEnrolling by invitation
50 participants
Started: Oct 31, 2013 · Completed: Dec 31, 2026
NCT02684474Collaborator
Expanded Access Protocol Using HBOC-201
N/ANO_LONGER_AVAILABLE
NCT03633604Collaborator
Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia
N/AAVAILABLE
Locations (1)
Headquarters
Souderton, PA, United States
Map
Loading map...